Business
Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing
New Executives Bring Decades of Healthcare Industry Experience and Knowledge of the Nitric Oxide Market to Beyond Air in Preparation for Launch of LungFit® PH
About this update from Beyond Air, Inc.
[{"type":"text","content":"New Executives Bring Decades of Healthcare Industry Experience and Knowledge of the Nitric Oxide Market to Beyond Air in Preparation for Launch of LungFit® PH in the US\nGARDEN CITY, N.Y., May 20, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced the appointments of Rebecca Van Doren as Head of Sales and Kori-Ann Taylor as Head of Marketing. Ms. Van Doren and Ms. Taylor each bring decades of healthcare industry leadership experience and in-depth knowledge of the nitric oxide market, working with Ikaria and then Mallinckrodt Pharmaceuticals to successfully drive sales and marketing initiatives for the current NO market leader. “On behalf of Beyond Air, I am delighted to welcome Rebecca and Kori-Ann, who both come to us with extensive nitric oxide experience in the commercial setting and intimate knowledge of the competitive landscape. These two appointments are part of our strategy to build a strong commercial team, which is crucial to the success of LungFit® PH, and an essential part of growing the entire LungFit® franchise,” said Duncan Fatkin, Chief Commercial Officer of Beyond Air. “I firmly believe that our generator-based delivery system can be the transformative technology in the respiratory care space with the potential to change how nitric oxide is used to the benefit of both patients and hospitals. As we prepare for a focused launch of LungFit® PH in the US for PPHN, the Company will rely on a select group of industry veterans to spearhead this effort.” Rebecca Van Doren brings over 20 years of healthcare leadership and sales experience to Beyond Air, dedicating the majority of her career to envisioning and invigorating winning commercial strategies for nitric oxide, both in the US and Australia with Ikaria and Mallinckrodt Pharmaceuticals. She has crafted and led commercialization programs for medical device and pharmaceutical products in global companies, including, most recently, Fresenius Medical Care. As an accomplished commercial leader, Ms. Van Doren unites business with science into comprehensive, global pr...